The American laboratory Merck announced on Monday that it had filed an authorization request with the American authorities for its pill against Covid-19, which could constitute a major advance in the fight against the pandemic.
Read also Merck: the impact of the pandemic on sales begins to fade
This request concerns Merck's drug, dubbed molnupiravir, for the treatment of adult patients with mild to moderate forms of Covid-19 who are at risk of progressing to severe forms and / or hospitalization, the company said in a statement.
